| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.6 | 0.03 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |